Pages that link to "Q37595954"
Jump to navigation
Jump to search
The following pages link to Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas (Q37595954):
Displayed 22 items.
- Prediction of therapy response in ovarian cancer: Where are we now? (Q39263260) (← links)
- Validation and application of a novel integrated genetic screening method to a cohort of 1,112 men with idiopathic azoospermia or severe oligozoospermia (Q40096374) (← links)
- Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life (Q40150370) (← links)
- An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice (Q47351280) (← links)
- Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature. (Q48110433) (← links)
- Accurate detection of low-level mosaic mutations in pediatric acute lymphoblastic leukemia using single molecule tagging and deep-sequencing. (Q48146880) (← links)
- Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. (Q48251790) (← links)
- Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome. (Q48268585) (← links)
- Mainstreaming genetics in palliative care: barriers and suggestions for clinical genetic services. (Q49843939) (← links)
- Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer. (Q52941950) (← links)
- Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus. (Q55313718) (← links)
- BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso (Q56335931) (← links)
- Tumor evolution and chemoresistance in ovarian cancer (Q58733743) (← links)
- Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma (Q64083374) (← links)
- Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol. (Q64974185) (← links)
- Potent immunogenicity in BRCA1-mutated patients with high-grade serous ovarian carcinoma. (Q64990659) (← links)
- Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon? (Q90274633) (← links)
- Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC) (Q90460653) (← links)
- Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer (Q90642678) (← links)
- Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic Cancer (Q91620888) (← links)
- Incorporation of semi-quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 and BRCA2 genes (Q92170461) (← links)
- Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition (Q95728398) (← links)